Please login or register first to view this content.
Cardiovascular Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
USPSTF: Evidence Lacking for Use of Vitamins for CVD, Cancer Prevention
Adding Aspirin to DOAC Therapy Without Clear Indication May Increase Bleeding Risk
Farxiga Approved for Patients With CKD at Risk of Progression
Review: Meds to Lower BP May Cut Risk for Major CV Events
Consider Meds for Persistent Stage 1 HTN at 6 Months
DOACs Appear Safer Than Warfarin Across Chronic Kidney Disease Stages
QTc Interval Prolonged in Some Hospitalized With COVID-19
USPSTF Reaffirms Benefit of Hypertension Screening for Adults
FDA Clears Novel Device for Upper Extremity Rehabilitation After Stroke
Case Report: Vitamin C Rapidly Reverses Pulmonary HTN Secondary to Scurvy
USPSTF: Evidence Lacking for A-Fib Screening in Asymptomatic Seniors
Potential Drug Interaction Between Warfarin, COVID-19 Treatment Reported
Diovan Approved for Younger Patients With Hypertension
Gender-Affirming Hormone Therapy Tied to Systolic BP Changes
Higher Red Meat Intake Tied to Worse Imaging Measures of CV Health
Chronic Adverse Effects From Anti-PD-1 Immunotherapies Common
Rare Thrombosis, Thrombocytopenia Seen After AstraZeneca COVID-19 Vaccine
Mortality Lower With PDE5i Treatment in Men With Stable CAD
